secwatch.observer — SEC 8-K summary
======================================

Issuer:     Unicycive Therapeutics, Inc. (UNCY)
CIK:        0001766140
Form:       8-K
Filed at:   2023-09-25T23:59:59+00:00
Accession:  0001213900-23-079139
Event type: regulatory
Sentiment:  negative
Materiality: 0.75
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Unicycive receives Nasdaq deficiency notices for market value <$35M and bid price <$1.00
--------------------------------------------------------------------------------

- On Sept 19, 2023, Nasdaq notified UNCY its market value of common stock was below $35M minimum for 30 consecutive business days.
- Also on Sept 19, bid price closed below $1.00 per share for 30 consecutive business days, violating Nasdaq Listing Rule 5550(a)(2).
- Company has 180 calendar days, until March 18, 2024, to regain compliance for both requirements.
- If compliance not regained, common stock may be delisted; Company can appeal to a Hearings Panel.
- Company intends to monitor market value and evaluate options to regain compliance, but no assurance given.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023079139/0001213900-23-079139-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1766140/000121390023079139/ea185665-8k_unicycive.htm
  HTML page:      https://secwatch.observer/filing/0001213900-23-079139

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer